Company / Free Cash Flow
Eledon Pharmaceuticals, Inc. Free Cash Flow History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$21.1M
FY2016
5-year range
-$21.1M / -$9.3M
FY2014-FY2016
Trend
-36.4%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$9M to -$21M over the past 2 years.
Based on SEC 10-K filings.
-$21M in FY2016.
Declined from -$9M to -$21M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, free cash flow decreased 36.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.62 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$21.1M | -36.4% |
| FY2015 | -$15.5M | -65.9% |
| FY2014 | -$9.3M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026